Sagar Lonial, MD and Robert Orlowski, MD, PhD

In this segment, “Emerging Therapies in Multiple Myeloma”, Sagar Lonial, MD and Robert Orlowski, MD, PhD highlight some novel therapies in development.

Despite major advances in multiple myeloma (MM), the disease remains incurable for many patients and new strategies are needed. Currently, many agents are in clinical trials for MM, including BCMA-targeted immunotherapy/CAR-T cells and a diversity of targeted therapies (e.g., BCL-2 and MCL-1 inhibitors).

Share this story, choose your platform!